William E Mitch

William E Mitch, M.D. is a Professor in the Department of Medicine-Nephrology at Baylor College of Medicine. His career has focused on understanding and mitigating the metabolic complications of chronic kidney disease (CKD), particularly muscle wasting and insulin resistance. He holds appointments at Houston, TX-based clinical and research institutions, including the Baylor Clinic. Dr. Mitch's research integrates clinical practice with experimental studies to address protein metabolism dysregulation in catabolic states, such as CKD and cancer cachexia.

Education: He completed medical training at Harvard Medical School (MD, 1967), followed by residencies and fellowships at Brigham and Women’s Hospital and Johns Hopkins Affiliate Hospitals, with advanced training at the National Cancer Institute. His certifications include Internal Medicine and Nephrology from the American Board of Internal Medicine.

Research Interests: His work emphasizes mechanisms of muscle proteolysis in CKD, including roles of ubiquitin-proteasome system, caspase-3 activation, and signaling pathways like STAT3 and Notch. He explores therapeutic interventions targeting muscle atrophy, vascular complications (e.g., arteriovenous fistula failure), and metabolic cross-talk between muscle, kidney, and adipose tissues.

Key Contributions: Pioneered studies linking CKD to insulin resistance, identified SIRPα as a mediator of CKD-induced cardiomyopathy, and developed dietary strategies to slow kidney disease progression. His research also addresses vascular calcification, fibrosis, and inflammatory pathways in CKD-associated cardiovascular disease.

Professional Activities: Editorials, reviews, and leadership in the field, including the 2004 JASN Presidential Address. Active in translational research, with studies on therapeutic compounds targeting STAT3, myostatin, and Notch signaling pathways.